Analyst Ratings for Cohen & Steers Inc. (CNS)

Updated: 2017-07-27

Shares of Cohen & Steers Inc. (NYSE:CNS) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for CNS last month.

3 analysts declared CNS a buy, 0 gave an overweight rating, 3 gave a hold rating, 1 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

CNS was given price targets by several analysts. The maximum price target given was 46, implying potential capital gains of 10.84 percent. The minimum price target given was 35, implying potential capital losses of -15.66 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Analysts have revised their earnings estimates upwards for this quarter, by about 4.04 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 4.04 percent. Meanwhile, fiscal year estimates have been revised upwards by 2.82 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 2.82 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 3 analysts revised their FY earnings estimates upwards, compared to 0 analysts that revised their FY estimates downwards.

CNS has an estimated earnings growth rate of -3.87 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. CNS has a PEG ratio of -5.2.

CNS has a 52-week high of 43.54 and a 52-week low of 33.16. Currently the stock is 25.15 percent higher than its low, and 4.69 percent lower than its 52-week high. CNS has a P/E ratio of 20.13. Investors typically compare the P/E ratio to a company's peers in the industry. The CNS value stock report compares CNS to some of its peers using value stock charts. The market cap of CNS is $1.94 billion. CNS's next earnings release will be on 0000-00-00, which is days away.